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Objectives:  To  evaluate  the  reliability  of magnetic  resonance  imaging  (MRI)  for the  diagnosis  of  middle
ear  cholesteatoma  and  to determine  the  contribution  of  each  MRI  sequence.
Patients and  methods:  A  series  of  97  cases  was  reviewed,  corresponding  to 89  patients  (43  women,
46  men).  Each  patient  was  assessed  by  the  following  MRI  protocol:  T1-weighted,  T2-weighted,
early  contrast-enhanced  T1-weighted,  delayed  contrast-enhanced  T1-weighted,  and  diffusion-weighted
sequences.  All  patients  were  operated,  for the  ﬁrst  time  in  16  cases  and  for second-look  surgery  in 81 cases.
Radiological  ﬁndings  were  compared  to surgical  and  histological  ﬁndings.  Sensitivity,  speciﬁcity,  positive
predictive  value,  and  negative  predictive  value  were  calculated  for each  sequence.
Results: Seventy-four  cholesteatomas  were  diagnosed  at  surgery.  These  lesions  had  a mean  diameter  of
8.29 ± 5.46  mm.  The  smallest  cholesteatoma  in this  series  was  2 mm  in  diameter.  Diffusion-weighted  and
delayed  contrast-enhanced  T1-weighted  sequences  had  a sensitivity  of  84.9%  and 90.4%,  a  speciﬁcity  of
87.5%  and  75%,  a positive  predictive  value  of 95.4%  and  91.7%,  and a  negative  predictive  value  of 65.6%
and  72%,  respectively.  T1-weighted,  T2-weighted,  and  early  contrast-enhanced  T1-weighted  sequences
had a low  speciﬁcity.
Conclusions:  MRI  is a reliable  imaging  modality  for  the diagnosis  of  middle  ear cholesteatoma.  Diffusion-
weighted  and  delayed  contrast-enhanced  T1-weighted  sequences  were  discriminant.  In the  context  of
postoperative  follow-up  of  cholesteatoma,  these  sequences  allow  better  selection  of cases  requiring
second-look  surgery.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Middle ear cholesteatoma is deﬁned as the presence of ker-
tinized squamous epithelium in the middle ear cavities. In the
ast majority of cases, the positive diagnosis of cholesteatoma
s based exclusively on clinical examination, especially otoscopic
ndings. Computed tomography (CT) is recommended in the con-
ext of preoperative assessment of cholesteatoma [1] in order to
xclude osteitis complications, to try to specify extensions of the
holesteatoma and to evaluate the anatomical conformation of the
ympanomastoid cavity. In some cases, when the diagnosis cannot
e conﬁrmed by clinical examination alone, CT scan can provide
DOI of original article: http://dx.doi.org/10.1016/j.aforl.2014.01.015.
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ttp://dx.doi.org/10.1016/j.anorl.2013.08.002arguments in favour of cholesteatoma by showing opacity with
rounded contours associated with adjacent osteolysis [2].
The treatment of cholesteatoma is surgical, based on two tech-
niques, called canal wall up (CWU) and canal wall down (CWD)
tympanoplasty. CWU  tympanoplasty ensures a more comfortable
postoperative course for the patient, but is associated with a higher
residual cholesteatoma rate [3]. Tympanic membrane grafting also
prevents satisfactory otoscopic surveillance. For these reasons, sys-
tematic second-look surgery was  performed 12 to 18 months after
a ﬁrst CWU  tympanoplasty to detect and treat any residual lesions.
Computed tomography, as well as conventional morphological
magnetic resonance imaging (MRI) T1-weighted, T2-weighted, and
early contrast-enhanced T1-weighted sequences have been shown
to present a number of limitations for the surveillance of patients
operated for middle ear cholesteatoma [4].
Over the last decade, a number of studies have tended
to demonstrate the capacity of new MRI  sequences to distin-
guish cholesteatoma from other types of postoperative opacities,
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uestioning the need for systematic second-look surgery: delayed
ontrast-enhanced T1-weighted sequences 45 to 60 minutes after
adolinium injection [5,6] and diffusion-weighted imaging (DWI)
7].
In this study, we tried to evaluate the contribution of each MRI
equence and combinations of the various sequences to the diag-
osis of middle ear cholesteatoma based on systematic surgical
onﬁrmation of imaging ﬁndings.
. Patients and methods
A single-centre, prospective, longitudinal study was  conducted
rom June 2004 to January 2011 in a series of 89 patients (43 women
nd 46 men, M/F  sex ratio: 1.07), with a mean age of 41 ± 21 years
t the time of MRI. All patients presented an indication for mid-
le ear surgery in the context of management of cholesteatoma
ﬁrst surgery or second-look surgery). All patients were assessed
y preoperative temporal bone MRI  in the same neuroradiology
epartment on a Siemens Avanto 1.5 Tesla machine (Magne-
om Avanto, Siemens Medical Solutions, Erlangen, Germany) or
 Siemens Sonata 1.5 Tesla machine (Magnetom Sonata, Siemens
edical Solutions, Erlangen, Germany). The following protocol
as systematically applied: axial and/or coronal unenhanced T1-
eighted spin echo sequences, axial and/or coronal T2-weighted
pin echo sequences, coronal and axial early contrast-enhanced T1-
eighted fat-saturated spin echo sequences, coronal and axial early
ontrast-enhanced T1-weighted fat-saturated spin echo sequences
0 to 60 minutes after gadolinium injection, coronal or axial
iffusion-weighted imaging, with axial echo planar imaging (EPI)
equences (sonata machine) or coronal non-echo planar imaging
alf Fourier single-shot turbo spin echo (EPI HASTE) sequences
Avanto machine), with a b value of 1000 mm2/s, without measur-
ng the apparent diffusion coefﬁcient. MRI  images were interpreted
efore surgery by the senior radiologist in charge of the examina-
ion. Each examination was interpreted by a single radiologist. A
otal of ﬁve different radiologists, all experienced in the interpre-
ation of temporal bone imaging, were involved in the study. The
arious MRI  sequences were not interpreted separately and, when
ecessary, were overlayed with lesion marking by software pro-
ided by the manufacturer. The size of the lesions was determined
n DWI.
All patients were operated by the same surgical team. The mean
nterval between MRI  and surgery was 4 months. All data con-
erning the surgical procedure were retrieved from the operation
eport. The presence or absence of cholesteatoma was  recorded and
onstituted the “gold standard” for the detection of cholesteatoma
n this study, and was used as the basis for all statistical anal-
ses. Cases of hyperkeratosis and retraction pockets ﬁlled with
quames (precholesteatomatous state) were classiﬁed with true
holesteatomas. The presence of other abnormalities such as ﬁbro-
is, inﬂammation, cholesterol granuloma, meningocele, or abscess
as also noted. Histological examination was performed to con-
rm the diagnosis. Two separate operations on the same ear were
erformed in eight patients and MRI  was performed before each
f these operations, resulting in a total cohort of 97 cases. Sixteen
ases (16.49%) were operated for the ﬁrst time and the ear had
een previously operated in 81 cases (83.51%). The mean interval
etween the date of previous surgery and MRI  for these 81 cases
as 31 months.
Sensitivity (Se), speciﬁcity (Sp), positive predictive value (PPV)
nd negative predictive value (NPV) values for each MRI  sequence
ere calculated (together with their 95% conﬁdence intervals) on
he basis of operative ﬁndings. The results of the “EPI DWI” and
Non-EPI DWI” groups were analysed separately and the areas
nder the ROC curve ((Se + Sp)/2) were compared between thegy, Head and Neck diseases 131 (2014) 153–158
two groups. A similar analysis was  also performed between “ﬁrst
surgery” and “previously operated ear” groups.
The normal distribution of quantitative variables was veriﬁed by
the Shapiro-Wilk test; quantitative data were compared between
groups by Student’s test or Mann-Whitney test when the condi-
tions of Student’s test were not met. Qualitative parameters were
compared by Fisher’s exact test or Chi-square test.
All analyses were performed with a type 1 error of 5% using
STATA v.10 software (Stata Corp).
3. Results
Seventy-four cases of cholesteatomatous lesions were diag-
nosed during surgery, i.e. in 76.29% of cases. These cases included
63 cholesteatomas (Fig. 1), ﬁve cases of hyperkeratosis, two
cholesteatomas associated with cholesterol granuloma, and four
retraction pockets ﬁlled with squames. Another 23 cases (23.71%)
presented inﬂammatory lesions in eight cases, ﬁbrotic lesions in
11 cases, a simple retraction pocket in one case, one mastoid
abscess, one meningocele, and total absence of lesions in one case.
Histological examination was  performed in 88 of the 97 cases and
conﬁrmed the surgical ﬁndings in every case. All MRI  characteris-
tics of middle ear cholesteatoma and its differential diagnoses are
summarized in Table 1.
The lesions detected had a mean diameter of 8.29 ± 5.46 mm.
The smallest cholesteatoma measured 2 mm in diameter (Fig. 2)
and the largest cholesteatoma measured 25 mm in diameter. T1-
weighted, T2-weighted, and early contrast-enhanced T1-weighted
sequences presented a sensitivity of 98.6, 91.8 and 95.9%, and a
speciﬁcity of 4.2, 20.8 and 29.2%, respectively. DWI  and delayed
contrast-enhanced T1-weighted sequences had a sensitivity of
84.9% and 90.4%, a speciﬁcity of 87.5% and 75%, a positive pre-
dictive value of 95.4% and 91.7%, and a negative predictive value
of 65.6% and 72%, respectively. Se, Sp, PPV, and NPV values for
each sequence are presented in Table 2 together with their 95%
conﬁdence intervals.
Enhancement of a peripheral rim on delayed contrast-enhanced
T1-weighted sequences of cholesteatoma was  present in only 30
(40.5%) of the 74 cases.
Diffusion-weighted imaging (DWI) sequences were acquired by
EPI in 10.3% of cases and non-EPI HASTE in 89.7% of cases. In the “EPI
DWI” group, DWI  had a sensitivity of 57.1% [18.4–90.1], a speciﬁcity
of 100% [29.2–100], a positive predictive value of 100% [39.8–100], a
negative predictive value of 50% [11.8–88.2], and an area under the
ROC curve of 0.79 [0.59–0.98]. In the “Non-EPI DWI” group, DWI  had
a sensitivity of 87.9% [77.5–94.6], a speciﬁcity of 85.7% [63.7–97], a
positive predictive value of 95.1% [86.3–99], a negative predictive
value of 69.2% [48.2–85.7], and an area under the ROC curve of 0.87
[0.78–0.95]. Comparison of areas under the ROC curve revealed a
signiﬁcant difference between the two  groups (P < 0.05).
No signiﬁcant difference was observed between the “ﬁrst
surgery” and “previously operated ear” groups.
The two  cases of cholesterol granuloma were associated
with cholesteatoma, with a false-negative result in one case:
radiological diagnosis of isolated granuloma, while the associ-
ated cholesteatoma was not detected. Two  false-negatives were
observed among the ﬁve cases of hyperkeratosis (6.75% of all
cholesteatomatous lesions) and one false-negative was observed
among the four cases of retraction pockets ﬁlled with squames. The
case of mastoid abscess corresponded to a false-positive, in the con-
text of a lesion measuring 28 mm in diameter. One case of isolated
meningocele was correctly diagnosed on the frontal T1-weighted
sequence. Discordant results between DWI  (absence of high-
intensity signal) and the delayed contrast-enhanced T1-weighted
sequences (absence of enhancement) were observed in four cases,
in which the intraoperative diagnosis was cholesteatoma.
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Fig. 1. MRI  of the left temporal bone, coronal section: isointense signal of the left lateral attic on unenhanced T1-weighted sequence (A), hyperintense signal on the
T2-weighted sequence (B), with no gadolinium enhancement, even at the late phase (C), and hyperintense signal on DWI  (D). Typical appearance of residual cholesteatoma.
Table 1
Signals observed on MRI  after middle ear surgery according to the various tissues.
Disease T1 signal T2 signal Early contrast-enhanced Delayed contrast-enhanced DWI  signal
Cholesteatoma Iso/Hypo Hyper No No Hyper
Abscess Hypo Hyper No No Hyper
 
 
s 
4
a
T
SCholesterol granuloma Hyper Hyper No
Fibrosis Iso/Hypo Hyper No
Inﬂammation Iso/Hypo Hyper Ye
. DiscussionStudies on the role of conventional T1-weighted, T2-weighted,
nd early contrast-enhanced T1-weighted MRI sequences in the
able 2
ensitivity (Se), speciﬁcity (Sp), positive predictive value (PPV), negative predictive value
T1 (%) T2 (%) Early contrast-enha
Se 98.6 [92.6–100] 91.8 [83–96.9] 95.9 [88.5–99.1]
Sp  4.2 [0.1–21.1] 20.8 [7.1–42.2] 29.2 [12.6–51.1]
PPV  75.8 [65.9–84] 77.9 [67.7–86.1] 80.5 [70.6–88.2]
NPV  50 [1.3–98.7] 45.5 [16.7–76.6] 70 [34.8–93.3] No Hypo
Yes Hypo
Yes Hypo
surveillance of operated cholesteatoma have demonstrated that
inﬂammatory tissue and cholesterol granuloma can be easily diag-
nosed on these sequences [8] (Table 1), but that cholesteatoma
and ﬁbrosis are more difﬁcult to diagnose. In 1999, based on a
 (NPV) of each MRI  sequence expressed as percentage and 95% conﬁdence interval.
nced T1 (%) Delayed contrast-enhanced T1 (%) DWI  (%)
 90.4 [81.2–96.1] 84.9 [74.6–92.2]
 75.0 [53.3–90.2] 87.5 [67.6–97.3]
 91.7 [82.7–96.9] 95.4 [87.1–99.0]
72.0 [50.6–87.9] 65.6 [46.8–81.4]
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2-weighted sequence (B), with no gadolinium enhancement, even at the late phas
eries of 18 patients, Van den Abeele et al. [9] reported a sensi-
ivity of 14.23%, while Williams et al. [5] reported a speciﬁcity of
3% for early contrast-enhanced T1-weighted sequences for the
etection of residual cholesteatoma. Delayed contrast-enhanced
1-weighted sequences and DWI  were not used in these two stud-
es. In the present series, the main limitation of T1-weighted,
2-weighted, and early contrast-enhanced T1-weighted sequences
oncerned their low speciﬁcity (Table 2), in line with the data
f the literature. The main value of the unenhanced T1-weighted
equence is for detection of cholesterol granuloma, while the
2-weighted sequence constitutes a morphological sequence for
ocalization of the cholesteatoma in combination with DWI.
Two main studies [5,6] have demonstrated an improvement of
he speciﬁcity and NPV for the detection of residual cholesteatoma
ollowing CWU  tympanoplasty by the use of delayed contrast-
nhanced T1-weighted sequences. For example, Ayache et al. [6],
eported the following values: Se: 90%, Sp: 100%, PPV: 100% and
PV: 92%. Our results are concordant with these data. However,
 number of lesions, although presenting radiological criteria for
holesteatoma, would not have been detected without DWI, essen-
ially for reasons of size. Williams [5] and Ayache [6] already
oncluded in their respective publications that the limit of the
echnique was related to the size of the lesion, while emphasiz-
ng the fact that missing a lesion smaller than 3 mm would beeral attic on unenhanced T1-weighted sequence (A), hyperintense signal on the
and hyperintense signal on DWI  (D). Left attic cholesteatoma 2 mm in diameter.
associated with a very low risk in view of the slow growth rate of
cholesteatoma [10], which would eventually be detected by subse-
quent MRI  follow-up. Venail et al. [11] estimated the mean growth
rate of residual cholesteatoma to be 2.74 mm per year.
The ﬁrst reported use of diffusion-weighted imaging for the
diagnosis of residual cholesteatoma was published in 2002 [12].
Stasolla et al. [13], who  compared EPI DWI  with conventional MRI
sequences, reported the following values: Se 92% versus 92%, Sp
100% versus 25%, PPV 100% versus 55%, NPV 92% versus 75%. Venail
et al. [11] reported the following values: 60%, Sp 72.73%, PPV 80%,
NPV 50%, with a signiﬁcant increase of these values when the anal-
ysis was  conﬁned to lesions larger than 5 mm.  Highly discordant
results have been published in the literature; in 2009, Doshi et al.
[14] highlighted the difﬁculty of comparing the various studies
using EPI DWI  due to the variability of the imaging parameters and
technique used. Another explanation for these discordant results,
according to Venail et al. [11], is the marked variability of the size of
cholesteatomatous recurrences studied. Our data are in line with
those of the most recent literature [1,15], with values tending to
demonstrate that DWI  is a reliable examination for the surveillance
of operated cholesteatoma.
Published studies have mainly concerned the surveillance of
previously operated cholesteatomas, as the initial diagnosis of mid-
dle ear cholesteatoma is essentially based on clinical examination,
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ystematically completed by preoperative CT assessment. Fitzek
t al. [16], in 2002, analysed the results of DWI  for the detection
f primary cholesteatoma and concluded that EPI DWI  was  use-
ul in this indication, but that it could not replace other imaging
odalities, especially CT. No signiﬁcant difference was observed in
ur series between nonoperated and previously operated patients.
e can therefore conclude that DWI  is a reliable technique in both
ettings. DWI  should not be systematically performed prior to ﬁrst
urgery [1], but can constitute a valuable aid to diagnosis in doubtful
ases.
Comparing EPI and non-EPI DWI, De Foer et al. [17] reported
hat non-EPI turbo spin echo sequences were more reliable than
PI sequences. In a review of the literature published in 2011, Jindal
t al. [18] compared the results of eight studies on EPI DWI  versus
ight studies on non-EPI DWI, by pooling the sensitivity, speciﬁcity,
egative predictive and positive predictive values for each group of
tudies and demonstrated the superiority of non-EPI DWI  over EPI
WI, in line with the results of our study.
In 2003, Aikele et al. [19] deﬁned the limit of detection of EPI
WI  to be lesions with a diameter of 5 mm.  In 2005, Ayache et al.
eported a limit of detection of 3 mm only on delayed contrast-
nhanced T1-weighted sequences. In 2007, De Foer et al. [20]
roposed a limit of 2 mm with non-EPI DWI  and, in our study,
he smallest lesion detected by DWI  was 2 mm in diameter and
as also visible on the delayed contrast-enhanced T1-weighted
equence. However, this limit of detection must be interpreted cau-
iously, as DWI  is not a morphological sequence and is therefore not
ppropriate for precise measurements.
Venail et al. [11] reported an improvement of the sensitivity of
RI for small lesions by combining delayed contrast-enhanced T1-
eighted and DWI  sequences (55.56% versus 33.33% and 44.44%
eparately). They also considered that image analysis of contrast-
nhanced sequences required more experience than image analysis
f DWI  images. Several publications have reported this combi-
ation of sequences to be the most efﬁcient [11,21], with a risk
f diagnostic error in the case of isolated analysis of DWI  [15].
oreover, DWI  was incriminated in the four cases of discordant
esults between the two sequences observed in our study. Sys-
ematic acquisition of the two sequences in our series achieved a
atisfactory level of reliability, as the diagnosis, essentially based
n DWI  data, was conﬁrmed by the delayed contrast-enhanced
1-weighted sequence, while the approximate site visualized on
WI  was more clearly deﬁned by the delayed contrast-enhanced
1-weighted and T2-weighted sequences.
Other authors have proposed abandoning the use of gadolinium-
nhanced sequences. In a study published in 2010, Rajan et al. [22]
eported a paediatric series of 15 patients examined by HASTE DWI
non-EPI) before second-look surgery. Se, Sp, PPV, NPV values were
ll 100%. These authors concluded that HASTE DWI  is a technique
f choice in paediatric populations, especially as it is a rapid exam-
nation, without the need for injection and not requiring general
naesthetic. In 2010, De Foer et al. [23] conducted a retrospective
tudy of the value of non-EPI DWI, delayed contrast-enhanced T1-
eighted sequence, and a combination of the two  sequences for the
etection of cholesteatoma in a group of never-operated patients
57 cases) and a group of patients requiring second-look surgery
63 cases). Blinded image review was performed by four radiolo-
ists, who did not ﬁnd any signiﬁcant improvement of Se, Sp, PPV,
nd NPV when the two sequences were combined compared to DWI
lone. The authors consequently recommended abandoning the use
f gadolinium-enhanced sequences in this indication, conﬁning the
xamination to T1-weighted, T2-weighted, and DWI  sequences.Recent data of the literature tend to prove that MRI, especially
WI, allows more reliable selection of patients requiring second-
ook surgery [3,23] and the results of the present study are in
greement with the literature. Clark et al. [24] also emphasized
[gy, Head and Neck diseases 131 (2014) 153–158 157
the fact that all patients with reassuring MRI, who  were therefore
not operated, must continue to be followed to exclude a possible
lesion smaller than the limits of detection. This strategy does not
question our conclusions, in view of the low invasive potential of a
lesion measuring less than 2 mm.  No consensus has been reached
concerning the duration of surveillance; the Société franc¸ aise d’ORL
et chirurgie cervico faciale report [25] recommends ﬁrst follow-up
imaging 18 months after surgery. In the absence of any resid-
ual lesion, and when the patient remains asymptomatic, imaging
should be repeated 12 to 24 months later to exclude the hypothesis
of a false-negative ﬁrst MRI.
5. Conclusion
This study demonstrates the good reliability of MRI  for the diag-
nosis of middle ear cholesteatoma. The key sequence is non-EPI
DWI, which has a limit of detection of 2 mm,  but a poor lesion
localizing capacity, requiring the combined use of a more mor-
phological sequence. The reliability of MRI  is equivalent in the
setting of nonoperated or previously operated cholesteatoma. The
delayed contrast-enhanced T1-weighted sequence is the second
discriminant sequence for the detection of cholesteatoma. It is the
sequence of choice to conﬁrm the diagnosis when no obvious sig-
nal is detected on DWI  and it also has a good localizing capacity.
T1-weighted, T2-weighted, and T1 early contrast-enhanced T1-
weighted sequences have a low speciﬁcity.
MRI  has a limited place in the initial assessment of nonoperated
cholesteatoma: conﬁrmation of the diagnosis in the rare doubtful
cases, suspicion of neuromeningeal or labyrinthine complications.
In the context of follow-up of operated cholesteatoma, MRI  allows
better selection of patients requiring second-look surgery.
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